Stanton Glantz, PhD's blog

FDA Should Not Exclude Accessories from the Scope of the Deeming Rule

We just submitted this comment to FDA on the deeming rule.
 
 FDA Should Not Exclude Accessories from the Scope of the Deeming Rule
 
Docket No. FDA-2014-N-0189

Lauren K. Lempert, JD MPH and Stanton A. Glantz, PhD
 
Center for Tobacco Control Research and Education
University of California San Francisco
  Read more »

New paper: Clean indoor air laws and state tobacco control spending are effective in reducing young adult smoking

Matthew Farrelly and collaegaues at RTI and the CDC Office on smoking an health recently published a nice paper, "Are tobacco control policies effective in reducing young adult smoking?" in Journal of Adolescent Health that shows that spending on state tobacco control programs and clean indoor air laws are associated with less young adult smoking.
 
Here is the abstract:
 
PURPOSE: Read more »

Judge Leon strikes again: His ruling on FDA’s Tobacco Advisory Committee is misguided and must be appealed

Judge Richard Leon, who has consistently ruled against the FDA on everything related to tobacco, is at it again, ruling that the FDA Tobacco Products Scientific Advisory Committee is flawed.  (Why does every tobacco case on the FDA end up in front of the same hostile judge?)
  Read more »

FDA cost-benefit analysis ignores that tobacco companies pass costs through to smokers, raising prices & reducing smoking

My colleagues at UCSF just submitted this comment to the FDA on the deeming rule:
 
The Regulatory Impact Analysis Must Consider the Benefits of the Likelihood that the Regulated Companies will Pass the Costs of Compliance on to Smokers, which Will Raise the Cost of the Regulated Products, thereby Reducing Consumption and Improving Health
 
Docket No. FDA-2014-N-0189
 
Hai-Yen Sung, PhD Read more »

The Regulatory Impact Analysis Fails to Adequately Document the Sources the Benefit and Cost Estimates upon Which it is Based

My UCSF colleagues just put in this public comment on the FDA deeming rule:
 
The Regulatory Impact Analysis Fails to Adequately Document the
Sources for the Benefit and Cost Estimates upon Which it is Based
 
Docket No. FDA-2014-N-0189
 
Wendy Max, PhD
Professor of Health Economics
 
Hai-Yen Sung, PhD Read more »

New sci-fi film identifies "Marlboro Light" as last cigarette on earth

According to the new sci-fi/horror film Snowpiercer (R, Weinstein), the last cigarettes on earth are Marlboro Light.
 
That’s what one train passenger cries out when another snaps open a cigarette case, eighteen years after the planet is flash-frozen. Other passengers stare at the two cigarettes in awe. Both cigarettes are smoked in the film.
___________________________
 
HELP US OUT!
  Read more »

New paper: Health Preemption Behind Closed Doors: Trade Agreements and Fast-Track Authority

Eric Crosbie, Mariaelena Gonzalez, and I just published a paper in American Journal of Public Health, "Health Preemption Behind Closed Doors: Trade Agreements and Fast-Track Authority," that describes how trade agreements such at the Trans Pacific Parnership, which are being negotiated in secret, can have the effect of preempting a wide range of health and safety laws, notably tobacco control policies, which are adopted at all levels of government.
 
Here is the abstract:
  Read more »

TRANSFORMERS TURNS AN AFTERNOON AT THE MOVIES INTO A LOUD CIGAR COMMERCIAL

TRANSFORMERS  MAKES 3 BILLION TOBACCO IMPRESSIONS ON CHINA AND USA
 
In three short weeks, Transformers: Age of Extinction (PG-13) has delivered an estimated 2.4 billion tobacco impressions in China and 1.5 billion tobacco impressions in the US and Canada.
 
The Viacom movie has earned 72 percent of its box office outside the US so far, including a record $280 million in China — surpassing its $209 million domestic box office. About half the movie is set in (or above) Hong Kong SAR. Read more »

FDA Should Clarify that Tobacco Products with Inadequate SE Applications Must be Removed from the Market

We just submitted this public comment to FDA on the FDA's proposed guideline tightening up the process for evaluating substantial equivalence claims.  (The proposed guideline is available here.)  While we think that this is a step in the right direction, we think that the FDA needs to be more explicit about how it is handling inadequate applications.  (This is different from deeming.) Read more »

Shareable microsite to generate comments to the FDA deeming docket

Tobacco Free Kids has created a microsite --  http://regulateALLtobacco.org -- aimed at generating comments to the FDA deeming docket to counter the tens of thousands of comments being submitted by cigar lovers and vapers.   Their goal is to distribute the URL far and wide so groups can share with members, generate alerts, put in newsletters, etc.  While theoretically the comment process should be about quality not quantity, quantity does count.
  Read more »

Syndicate content